🔗 Visit the ClinicalTrials.gov page for NCT00642460
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. | N Engl J Med | 2012 | 4.15 |
| 2 | Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis. | Arthritis Res Ther | 2009 | 1.26 |
| 3 | Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. | Cancer Growth Metastasis | 2015 | 0.90 |
| 4 | Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial. | Arthritis Rheumatol | 2015 | 0.75 |